Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Instagram Outage Disrupts Thousands of U.S. Users 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TROY, Mich., Oct. 25, 2016 -- DirectRx Pharmacy, a leading independent pharmacy accredited by URAC, ACHC, NABP and WBENC, has won a competitive bid for nebulizers and related supplies from the Centers for Medicare & Medicaid Services (CMS) under Round 1 2017 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) competitive bidding program. The contract will apply from January 1, 2017 through December 31, 2018.
Under the new CMS contract, DirectRx Pharmacy will supply nebulizer equipment and supplies for Medicare clients in Kansas City, Mo. and Dearborn, Franklin, Ohio and Union counties, Ind. DirectRx specializes in treating COPD and other respiratory conditions using integrated care and follow-up, as well as leading medications such as Brovana, Budesonide and Perforomist.
“DirectRx is proud to be awarded this contract so that we can further our vision of helping patients with respiratory conditions such as asthma and COPD,” said Amanda Berishaj, PharmD, of DirectRx. “COPD, chronic bronchitis, emphysema and other respiratory conditions can be treated. With COPD, the key is treating the condition early to improve how well your lungs work.”
The DMEPOS Competitive Bidding Program was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The Centers for Medicare & Medicaid Services, CMS, is part of the Department of Health and Human Services (HHS).
DirectRx Pharmacy, an independent, family-owned pharmacy accredited by URAC, ACHC, NABP and WBENC, is dedicated to providing patients with unparalleled, personalized pharmaceutical care for their specialty pharmacy needs. Unlike other pharmacies, DirectRx is owned and operated by certified doctors of pharmacy. The company has grown to serve more than 38 states since its inception more than two decades ago. Investments in technology help to drive the best possible patient care and deliver the most accurate data to our partners. www.DirectRx.com
CONTACT: Amanda Berishaj, PharmD, DirectRx, (855) 362-3397
